and Herpes simplex virus (HSV). Of these, the furthest ahead in development is the RSV vaccine, which could launch later this year and would compete with products from GSK and Pfizer based on ...

The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...

Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...

GSK has announced a 50/50 joint venture with leading Indian vaccines company, Biological E, for the early stage research and development of a six-in-one combination paediatric vaccine to help ...

Teva Pharmaceutical Industries Ltd. ADR-1.51% $18.8B ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

After hours: 7:44:54 p.m. EST ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was up ...

When is the Ark 2 release date? Ever since the Ark 2 announcement at The Game Awards 2020, we’ve been looking forward to learning more about the upcoming dinosaur-themed survival game.

Three of these vaccines (diphtheria, tetanus, and pertussis) were combined into a single shot (DTP). Children received five shots by the time they were 2 years old and not more than one shot at a ...